Inflammatory Bowel Disease

What the poet John Donne observed about humanity — “no man is an island, entire of itself; every man is a piece of the continent, a part of the main” — holds true for health care providers. No provider operates in a vacuum; no provider stands alone.

Patients with inflammatory bowel disease and a higher percentage of intra-abdominal visceral adipose tissue were less likely to achieve corticosteroid-free remission when treated with biologics, according to data in Gastroenterology.

From the impact of Humira biosimilars flooding the U.S. market to shifting trends in colorectal cancer demographics, Healio has asked experts the big questions to stay abreast of the current hot topics in gastroenterology and hepatology.

In the latest installment of our diversity, equity and inclusion video series with ASGE, Anna H. Owings, DO, discusses racial disparities in treatment initiation and response in patients with inflammatory bowel disease.

Patients with inflammatory bowel disease infected with SARS-CoV-2 during the first and second waves of the pandemic experienced different symptoms and outcomes, consistent with those of the general population in Italy, researchers reported.

In my more than 30-year career as a registered dietitian in gastroenterology, it has been exciting to see the role of dietitians in gastrointestinal conditions become validated and expanded upon, most markedly over the past 10 years.

When it comes to dietary management of inflammatory bowel disease, it is important to make the distinction between diet and nutrition.

Cyltezo, the first interchangeable Humira biosimilar, officially entered the U.S. market on July 1, opening a floodgate that will see the release this month of half a dozen biosimilars for what has been the top selling drug in the country.

M. Elaine Husni, MD, MPH, spoke with Healio about treatment and management options in psoriatic arthritis, including lifestyle changes. “We now have really embraced the concept of wellness strategies,” said Husni, vice chair of rheumatology and director of the Arthritis and Musculoskeletal Center and staff physician in the Orthopedic and Rheumatologic Institute at Cleveland Clinic, and assistant professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

M. Elaine Husni, MD, MPH, spoke with Healio about treatment and management options in psoriatic arthritis, including lifestyle changes. “We now have really embraced the concept of wellness strategies,” said Husni, vice chair of rheumatology and director of the Arthritis and Musculoskeletal Center and staff physician in the Orthopedic and Rheumatologic Institute at Cleveland Clinic, and assistant professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.